Detalhe da pesquisa
1.
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
Dermatology
; 238(3): 487-497, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474409
2.
Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
Dermatol Ther
; 33(6): e14387, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33030281
3.
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
Dermatol Ther
; 32(2): e12792, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30515931
4.
Epidermal barrier reaction to an in vitro psoriatic microenvironment.
Exp Cell Res
; 360(2): 180-188, 2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28890293
5.
Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis.
Dermatol Ther
; 31(4): e12614, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29708289
6.
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study.
J Eur Acad Dermatol Venereol
; 2023 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062048
7.
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin.
Exp Cell Res
; 345(2): 247-54, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27207586
8.
Intellectual Disability and Hidradenitis Suppurativa.
Dermatology
; 237(3): 386-388, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33040054
9.
A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 Phototherapy.
Pediatr Dermatol
; 33(2): e99-102, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26871550
10.
SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis.
Dermatol Ther
; 33(3): e13435, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306527
11.
A rare case of anal porocarcinoma treated by electrochemotherapy.
Future Oncol
; 10(15): 2429-34, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25525852
12.
Tuberculosis reactivation risk in dermatology.
J Rheumatol Suppl
; 91: 65-70, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24789002
13.
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience.
Dermatol Ther
; 31(5): e12675, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30133998
14.
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.
Clin Cosmet Investig Dermatol
; 16: 847-852, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033782
15.
Etanercept restores a differentiated keratinocyte phenotype in psoriatic human skin: a morphological study.
Exp Dermatol
; 21(7): 549-51, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22716254
16.
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics.
Ital J Dermatol Venerol
; 157(6): 469-479, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785927
17.
Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
Curr Pharm Biotechnol
; 22(1): 73-84, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32525769
18.
A rare case of anal porocarcinoma treated by electrochemotherapy.
Future Oncol
; 11(4): 714, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25686124
19.
Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer.
Anticancer Res
; 40(11): 6485-6492, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33109587
20.
The psoriatic shift induced by interleukin 17 is promptly reverted by a specific anti-IL-17A agent in a three-dimensional organotypic model of normal human skin culture.
Eur J Histochem
; 64(2)2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32312032